ENTITY
Amgen Inc

Amgen Inc (AMGN US)

165
Analysis
Health CareUnited States
Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.
more
Refresh
06 Jul 2016 16:44

Brexit; Unintended Consequences

In this brief piece we take a considered stance on the likelihood of Brexit actually proceeding in the wake of June’s referendum and examine some...

Share
29 Jun 2016 21:19

The Path to No Brexit

In my last piece I discussed why I thought an actual Brexit was unlikely despite the result of the referendum last week. This piece answers some...

Logo
298 Views
Share
28 Jun 2016 01:35

Why Brexit (Probably) Won't Happen

The last few days have seen a maelstrom of opinions and recrimination after the shock referendum decision to leave the EU.The lack of a concrete...

Logo
583 Views
Share
26 Jun 2016 11:49

The Dark Side of Glocalization (Even if Investment Opportunities)

Last week in my notes I pointed to the investment world being upside down and there being too much risk to be fully invested.Let’s set aside...

Share
24 Jun 2016 16:11

Will Brexit Break EM's Back?

Against market expectations the British have voted to exit the European Union, a process that could take a few years. The first order impact is...

Logo
233 Views
Share
x